Viking Therapeutics Prices Upsized $500M Dual Capital Raise
Viking Therapeutics priced an upsized $500M capital raise, pairing $275M in common stock at $35 and $225M in 2% convertible senior notes due 2032.
vktx
Viking Therapeutics priced an upsized $500M capital raise, pairing $275M in common stock at $35 and $225M in 2% convertible senior notes due 2032.